Muscle Pharm Corp (MSLP) 2.7700 $MSLP MusclePharm

New Post Public Reply Private Reply Replies (0) Message Board

Jun 6, 2016 at 4:13 PM

Muscle Pharm Corp (MSLP) 2.7700 $MSLP

MusclePharm Corporation Announces More Than $45 Million in Future Commitments Trimmed To Date
PR Newswire - Thu May 26, 3:15PM CDT
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"

, a scientifically-driven, performance lifestyle sports nutrition company, announced a reduction of more than $45 million in future commitments to date as part the Company's ongoing restructuring program.

MusclePharm Reports 2016 First Quarter Financial Results
PR Newswire - Tue May 10, 4:00PM CDT
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"

, a scientifically-driven, performance lifestyle sports nutrition Company, today announced financial results for the first quarter ended March 31, 2016.

MusclePharm Enters into Agreement for the Sale of BioZone Laboratories
PR Newswire - Wed Apr 27, 8:49AM CDT
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"

, a scientifically-driven, performance-lifestyle sports nutrition company, announced today that it has entered into a definitive agreement for the sale of its wholly-owned subsidiary, BioZone Laboratories, Inc. ("BioZone"

.

MusclePharm Reports 2015 Fourth-Quarter And Full-Year Financial Results
PR Newswire - Thu Mar 17, 6:00AM CDT
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"

, a scientifically-driven, performance lifestyle sports nutrition company, today announced financial results for the fourth quarter and full year ended December 31, 2015.

MusclePharm hires former ConAgra Foods veteran to head Operations
PR Newswire - Thu Mar 03, 7:05AM CST
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"

, a scientifically-driven, performance lifestyle sports nutrition company, today announced the appointment of Jon Heussner as its Vice President of Operations.
CAG: 46.29 (-0.22)

MusclePharm Focused on Expanding Market Share in Growing Protein Sector
PR Newswire - Tue Jan 19, 7:15AM CST
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"

, a scientifically-driven, performance lifestyle sports nutrition company, announced the planned introduction of two protein products: Combat 100% Whey(TM) and Combat Pro-Gel(TM).

MusclePharm Completes $10 Million Financing
WorldStockWire - Thu Jan 14, 10:30PM CST
MusclePharm Corporation (OTCQB: MSLP) a scientifically-driven, performance lifestyle sports nutrition company, today announced the completion of a financing agreement with Prestige Capital Corporation ("Prestige Capital"

in the initial amount of $10 million.

MusclePharm Executive Chairman Issues Letter to Shareholders
BusinessWire - Thu Dec 10, 7:00AM CST
MUSCLEPHARM CORPORATION (OTCQB: MSLP), a scientifically driven, performance-lifestyle sports nutrition company, announced that it has released a letter from Executive Chairman Ryan Drexler to update shareholders on the current status of the Company.

MusclePharm to Explore Sale of Its BioZone Laboratories Nevada Subsidiary's Business
BusinessWire - Tue Nov 17, 7:00AM CST
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"

, a scientifically driven, performance-lifestyle sports nutrition company, today announced that it has previously retained an investment banker to explore the sale of all or substantially all of the assets of its BioZone Laboratories Inc. subsidiary.

Hynes Keller & Hernandez, LLC Announces Investigations of AAC Holdings, Inc., Muscle Pharm Corp., and Hill International, Inc.
PR Newswire - Wed Sep 23, 6:35AM CDT
Hynes Keller & Hernandez, LLC is investigating potential claims against AAC Holdings, Inc., Hill International, Inc. and Muscle Pharm Corp. as detailed below.
HIL: 4.40 (+0.08), AAC: 21.77 (+0.28)

MusclePharm Corp. Statement on SEC Settlement
BusinessWire - Tue Sep 08, 1:29PM CDT
MusclePharm Corporation (OTCQB: MSLP), a scientifically driven, performance-lifestyle sports nutrition company, today announced approval of the final settlement with the United States Securities and Exchange Commission, as was announced by the SEC earlier today.

SEC Charges Sports Nutrition Company With Failing to Properly Disclose Perks for Executives
M2 - Tue Sep 08, 11:21AM CDT
The Securities and Exchange Commission today charged a sports supplements and nutrition company with committing a series of accounting and disclosure violations, including the failure to properly report perks provided to its executives as compensation.

MusclePharm to Position Company for Future Profitability
BusinessWire - Tue Aug 25, 3:45PM CDT
MusclePharm Corporation (OTCQB: MSLP), a scientifically driven, performance-lifestyle sports nutrition company, today announced plans to better focus and align the company's resources toward profitable growth. The company believes this initiative could yield cost savings in excess of $20 million on an annual basis going forward, and profitability in 2016 and beyond. MusclePharm will be working to increase operating profit margins to 10 percent and earnings before interest, taxes, depreciation and amortization (EBITDA) margins to 15 percent by 2020.

MusclePharm Reports 2015 Second Quarter Financial Results
Marketwired - Mon Aug 10, 3:40PM CDT
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"

, a scientifically driven, performance-lifestyle sports nutrition company, today announced financial results for the second quarter ended June 30, 2015.

Glancy Prongay & Murray LLP is Investigating Muscle Pharm Corp. Board of Directors
BusinessWire - Tue Jul 21, 5:39PM CDT
Glancy Prongay & Murray LLP is investigating potential claims against the Board of Directors of Muscle Pharm Corp. ("Muscle Pharm" or the "Company"

(OTC:MSLP). This investigation concerns the Company's May 8, 2015 amendments to its By-laws and whether the Board of Directors of Muscle Pharm breached their fiduciary duties to stockholders by approving amendments which may place undue burden on stockholders' ability to nominate and elect competing directors to the incumbent slate.

MusclePharm Announce Signing UFC Fighters Robbie Lawler, Luke Rockhold and Paige VanZant
Marketwired - Wed Jul 08, 9:00AM CDT
MusclePharm Corporation (OTCQB: MSLP), a scientifically driven, performance-lifestyle sports nutrition company announced signing welterweight champion Robbie Lawler, number one middleweight contender Luke Rockhold, and rising star Paige VanZant in the strawweight division. Robbie Lawler will be featured in the co-main event at UFC 189 in Las Vegas this week to defend his welterweight title.

MusclePharm Announces Appointment of Experienced Nutrition and Fitness Executive and Investment Manager Ryan Drexler to Board of Directors
Marketwired - Thu Jun 25, 8:03AM CDT
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"

, a scientifically driven, performance-lifestyle sports nutrition company, today announced Ryan Drexler as its new chairman. The announcement is a part of the Company's continued effort to institute best-in-class corporate governance practices and fulfills its commitment to separate the roles of CEO and Chairman. Mr. Drexler is an experienced investor and manages Consac, LLC, based in Beverly Hills, California. Consac, which invests in publicly traded and venture companies in the health and wellness space, has made significant investments in MusclePharm's stock in the public market and in private transactions.

Author of Body-for-LIFE and Former CEO/Owner of EAS Performance Nutrition Bill Phillips Joins MusclePharm
Marketwired - Tue Jun 16, 6:00AM CDT
MusclePharm Corporation (OTCQB: MSLP), a scientifically-driven, performance-lifestyle sports nutrition company announces fitness and bodybuilding pioneer Bill Phillips joining MusclePharm as Strategic Advisor and Chief Editor of Content. Mr. Phillips is one of the most credible voices in the world on fitness and brings with him three decades of experience and knowledge in the nutritional and supplement field and a proven leader in science-based products. As a part of his scope, Mr. Phillips will also develop with MusclePharm a direct selling model aimed at the over 40 demographic -- a segment that the Company has not yet had a significant penetration in. This is expected to be launched by early 2016.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Coventry's Jacobs Joins European Life Settlement Execs

Neal Jacobs Steps Up in Life Settlements Coventry has added another feather to its cap with Neal Jacobs, their Senior Managing Director of Capital Markets, joining the Executive Committee of the European Life Settlement Association (ELSA). Elected at ELSA's Annual General Meeting on September 15, 2026, Jacobs brings a wealth of experience that promises to bolster the...

New Data on SKYRIZI Offers Hope for Crohn's Patients

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Fluence Energy Faces Major Lawsuit Amid $3B Loss

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Honeywell Aerospace Faces Legal Turbulence in Fraud Case

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Simple Home Upgrades That Boost Value Fast

Transform Your Home's Curb Appeal Without Breaking The Bank Every homeowner knows that feeling when you look at your house one day and think, "This could use a little something." Say you're strolling through a neighborhood in Fulton, N.Y., and notice a gem. It's not a brand new build, but it gleams with character. You bet it's had a few smart touches that could apply...

New American Funding Expands in Carolinas with Mullinix Move

The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...

Think Tank Pushes for Bold Parkinson's Prevention Plan

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Navigating Battery Compliance for AI Data Centers

Untangling the Web of Global Battery Compliance Amid clamor about AI's insatiable appetite for energy storage, the rules around shipping, installing, and handling data center batteries have become a tangled web. From Waxahachie, Texas, Americase International plans to take the stage at the OCP Global Summit on October 15, 2026, to spearhead a discussion on bridging the...

Paradigm Therapeutics: A Beacon in Rare Diseases

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

OmniActive's Fenavari: A New Era in Women's Health

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...